Search research articles
Contact Us
Filters
Showing results (61-70 of 99) with videos related to
Page
of 10
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 1, 2024
In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection
Christine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Lancet (London, England)
|
June 5, 2009
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial
Nubia Muñoz, Ricardo Manalastas, Punee Pitisuttithum, et al.
Infectious Diseases and Therapy
|
September 26, 2023
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial
F D Richard Hobbs, Hugh Montgomery, Francisco Padilla, et al.
Plos One
|
April 13, 2016
Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus
Sarah V Maifeld, Bodrey Ro, Hoyin Mok, et al.
Science Translational Medicine
|
July 20, 2022
A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques
Joseph P Nkolola, Jingyou Yu, Huahua Wan, et al.
Clinical and Vaccine Immunology : CVI
|
April 13, 2007
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines
Suzanne M Garland, Marc Steben, Mauricio Hernandez-Avila, et al.
Nature Communications
|
October 14, 2025
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19
Rhiannon Edge, Sam Matthews, Bahar Ahani, et al.
Journal of Clinical Microbiology
|
November 14, 2014
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia
Batu K Sharma-Kuinkel, Yuling Wu, David E Tabor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Charu Aggarwal, Nabil F Saba, Alain Algazi, et al.
Plos One
|
January 10, 2013
HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays
Shih-Wen Lin, Arpita Ghosh, Carolina Porras, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 99) with videos related to
Sort By:
Page
of 10
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 1, 2024
In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection
Christine Tkaczyk, Michael Newton, Mun Mun Patnaik, et al.
Lancet (London, England)
|
June 5, 2009
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial
Nubia Muñoz, Ricardo Manalastas, Punee Pitisuttithum, et al.
Infectious Diseases and Therapy
|
September 26, 2023
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial
F D Richard Hobbs, Hugh Montgomery, Francisco Padilla, et al.
Plos One
|
April 13, 2016
Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus
Sarah V Maifeld, Bodrey Ro, Hoyin Mok, et al.
Science Translational Medicine
|
July 20, 2022
A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques
Joseph P Nkolola, Jingyou Yu, Huahua Wan, et al.
Clinical and Vaccine Immunology : CVI
|
April 13, 2007
Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines
Suzanne M Garland, Marc Steben, Mauricio Hernandez-Avila, et al.
Nature Communications
|
October 14, 2025
A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19
Rhiannon Edge, Sam Matthews, Bahar Ahani, et al.
Journal of Clinical Microbiology
|
November 14, 2014
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia
Batu K Sharma-Kuinkel, Yuling Wu, David E Tabor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Charu Aggarwal, Nabil F Saba, Alain Algazi, et al.
Plos One
|
January 10, 2013
HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays
Shih-Wen Lin, Arpita Ghosh, Carolina Porras, et al.
Page
of 10